arrhythmia Atrial fibrillation
Conditions
Interventions
7-day ECG- monitoring using the Bittium Faros 360 at baseline (t=0), after
one(t=1) and two years (t=2).
Sponsors
Academisch Medisch Centrum
Eligibility
Age
65 Years to 99 Years
Inclusion criteria
Inclusion criteria: Aged 65 and over Not diagnosed with atrial fibrillation CHA2SD2VASc score of 4 or more for women and 3 or more for men
Exclusion criteria
Exclusion criteria: Legal incompetence Pacemaker/ICD
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameter will be the difference in the number of patients with newly found AF between the intervention and control arms over three years of follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Difference in incident AF yield between the screened patients in the interventionarm and all patients in control arms 2. Difference in time to diagnosis of AF between intervention and control practices. 3. Difference in other relevant cardiovascular outcomes like stroke, TIA, dementia, heart failure and use of anticoagulation therapy. 4. Difference in detection of new AF in control practices participating in the trial versus detection of AF in non-participating general practices in the network. 5. Patient experience with the monitoring device in the intervention group and how they think about the implementation of AF screening in the future. | — |
Countries
Netherlands
Outcome results
None listed